Chanez, Pascal <br/><br/>
Omalizumab-induced decrease of FcξRI expression in patients with severe allergic asthma.  [electronic resource] 

 -  Respiratory medicine  Nov 2010 
 - 1608-17 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1532-3064 
<br/><br/><label>Standard No.: </label>10.1016/j.rmed.2010.07.011  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Anti-Allergic Agents--therapeutic use<br/>Antibodies, Anti-Idiotypic<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Humanized<br/>Asthma--drug therapy<br/>Basophils--drug effects<br/>Dendritic Cells--drug effects<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Immunoglobulin Fc Fragments--metabolism<br/>Male<br/>Middle Aged<br/>Omalizumab<br/>Placebos<br/>Respiratory Function Tests<br/>Treatment Outcome<br/>Young Adult